Treatment of functionally insignificant vulnerable plaques in patients with ST-elevation myocardial infarction and multivessel disease. (VULNERABLE Study).
CLINICAL RESEARCH WITH PROD. SANIT.
Clinical trial information
- Promoter: EPIC FOUNDATION
- Execution start: 10/04/2023
- End of execution: 30/01/2029
- IP: JUAN CABALLERO BORREGO
